
Detailed patient-journey tracking and Forecasting for rare disease therapy
A specialty pharmaceutical company was planning to launch an oral prescription medication for treatment of seizures associated with a rare pediatric disease. The market landscape included several non-pharmacological therapies and non-targeted drugs.
Viscadia was asked to design and build a go-to-market forecasting model for tracking patient journeys and projecting demand on a weekly basis.